Drugs / Bicillin L-A
Regulatory milestones approvals, filings & regulatory actions · 5 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansions (4) | US (FDA) | BICILLIN L-A | — | 1954-10-21 – 1982-09-16 | fda.gov ↗ |
| Approved | US (FDA) | BICILLIN L-A | — | 1952-06-27 | fda.gov ↗ |
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00427609 Comparator | Jan 2007 → Nov 2009 | psoriasis | University of Tennessee | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bicillin L-A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00427609 ↗ |
| Route | Intramuscular | “Bicillin L-A administered intramusculary” NCT00427609 ↗ |